Arcus Biosciences boasts a diverse, promising pipeline with key candidates like domvanalimab, casdatifan, and quemliclustat advancing in pivotal trials. Recent data from RCUS's EDGE-Gastric trial show ...

Alzheimer’s disease affects millions of people around the world, slowly damaging memory, thinking, and behavior. For decades, scientists have searched for a way to stop or even slow down this ...